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ProlidaseshydrolyzeXaa-ProdipeptidesandcanalsocleavetheP-FandP-Obondsfoundinorganophosphorus(OP)compounds,
including the nerve agents soman and sarin. Ph1prol (PH0974) has previously been isolated and characterized from Pyrococcus
horikoshii and was shown to have higher catalytic activity over a broader pH range, higher aﬃnity for metal, and increased
thermostabilitycomparedtoP.furiosusprolidase,Pfprol(PF1343).ToobtainabetterenzymeforOPnerveagentdecontamination
and to investigate the structural factors that may inﬂuence protein thermostability and thermoactivity, randomly mutated Ph1prol
enzymeswereprepared.FourPh1prolmutants(A195T/G306S-,Y301C/K342N-,E127G/E252D-,andE36V-Ph1prol)wereisolated
which had greater thermostability and improved activity over a broader range of temperatures against Xaa-Pro dipeptides and OP
nerve agents compared to wild type Pyrococcus prolidases.
1.Introduction
Pyrococcus horikoshii and Pyrococcus furiosus are both hyper-
thermophilic archaea, growing optimally at 98–100◦C that
were isolated from a deep hydrothermal vent in the Okinawa
Trough in the northeastern Paciﬁc Ocean and from a shallow
marine solfatara at Vulcano Island oﬀ the coast of Italy, resp-
ectively [1, 2]. Pyrococcus spp. are some of the most studied
hyperthermophilic archaea to date owing in part to their
utility for a variety of biotechnological applications [3–7].
For example, recombinant prolidases from Pyrococcus spp.
are being studied for their potential use in bio-decontamina-
tion applications [8].
Prolidases function in vivo to hydrolyze dipeptides with
proline in the C-terminus, Xaa-Pro, and a non-polar amino
acid in the N-terminus [9] .H o w e v e r ,s t u d i e sh a v ed e m -
onstrated that prolidases can also hydrolyze and detoxify
organophosphate(OP)compoundssuchaschemicalwarfare
agents (CWA) [8]. Two enzymes that have been character-
ized for potential ﬁeld detoxiﬁcation of nerve agents are
organophosphorus acid anhydrolase (OPAA) and phospho-
triesterase (PTE) [10, 11]. Recently, the crystal structure of
OPAA from Alteromonas sp. JD6.5 strain has been solved,
and it has been determined to be a prolidase [12]. While
OPAA does have the capability to degrade OP nerve agents,
its activity can be limited by exposure to high temperatures
and solvents during use in ﬁeld situations [13, 14].
In 2008, the Defense Threat Reduction Agency (DTRA),
under the auspices of the Department of Defense recognized
the importance of developing enzyme-based OP nerve agent
detoxiﬁcation systems and created an initiative calling for
new enzymes and biocatalysts that are stable over a broad
temperature and pH range, in the presence of salts and
surfactants, and that do not pose an environmental hazard2 Archaea
[15]. In response to the need to develop stable OP nerve
agent degrading enzyme systems, thermostable prolidases
from Pyrococcus spp. were studied [16–18].
Speciﬁcally, Pyrococcus prolidases from P. furiosus
(PF1343 or Pfprol) and P. horikoshii (PH1149 or Phprol
andPH0974orPh1prol)werecharacterizedbothstructurally
and enzymatically [16, 18, 19]. The Pyrococcus prolidases
were determined to be very similar, with Pfprol showing
88% amino acid similarity to Phprol and 55% similarity
to Ph1prol. Although they have high similarity to each
other, the kinetic properties of Ph1prol appeared to be more
favorable for application purposes than those of Pfprol and
Phprol. Ph1prol has demonstrated higher activity at lower
temperatures and over a broader pH range. It has long-term
stability, higher aﬃnity for substrates, and a lower metal
requirementforcatalysis[16].Therefore,itwasdeemedtobe
advantageous to use Ph1prol in mutagenesis studies in order
to develop a better enzyme for OP nerve agent detoxiﬁcation
and to further investigate factors that inﬂuence the catalysis
of thermophilic metalloenzymes. To this end, a random mu-
tagenesis Ph1prol gene library was constructed and screened
for production of mutants that showed increased prolidase
activity at 30◦Cc o m p a r e dt ow i l dt y p ePh1prol. Four
Ph1prol mutants were isolated and subsequently character-
ized to determine their substrate catalysis over a broad range
of temperatures and their performance against OP nerve
agent analogs in comparison to Ph1prol and the previously
characterized Pfprol.
2.MaterialsandMethods
2.1. Bacterial Strains, Media, and Materials. The E. coli K-
12 derivative NK5525 (proA::Tn10) was used to construct
the selection strain JD1(λDE3) as described in [20]f o r
screening of cold-adapted P. horikoshii prolidase variants.
The P. horikoshii prolidase expression plasmid pET-Ph1prol
was previously constructed as described in [16]. The E.
coli strains were cultured either in Luria-Bertani (LB) broth
or M9 selective minimal medium supplemented with 0.2%
glucose, 1mM MgSO4, 0.05% VitB1,2 0 μMI P T G ,2 0 μM
Leu-Pro. Ampicillin (100μg/mL), kanamycin (50μg/mL),
chloramphenicol (34μg/mL), and tetracycline (6μg/mL)
were added into the medium when required.
2.2. Construction of a Pool of pET-Ph1prol Plasmids Encoding
Randomly Mutated P. horikoshii Prolidase Genes. Error-
prone PCR mutagenesis using the Genemorph II Random
mutagenesis kit (Stratagene, La Jolla, Calif) was used to
amplify and insert mutations into the P. horikoshii prol-
idase gene (PH0974). PCR ampliﬁcation was carried out
for 30 cycles: (60sec at 95◦C, 60sec at 55◦C, 120sec at
72◦C), with a 10-minute ﬁnal extension at 72◦C. Reactions
contained Mutazyme II reaction buﬀer, 125ng/μLo fe a c h
primer, 40mM dNTP mix, and 2.5U of Mutazyme II DNA
polymerase. Initial DNA template amounts used were 250ng
and 750ng in order to select for medium-to-low mutation
rates, respectively. The Genemorph II EZClone (Stratagene,
La Jolla, Calif) reaction was employed to clone the mutated
prolidase gene into the expression vector pET-21b.
The EZClone reaction included EZClone enzyme mix,
50ng of template plasmid (pET-prol), 500ng of megaprimer
(mutated prolidase PCR product), and EZClone solution.
The reactions were ampliﬁed for 25 cycles: (50sec at 95◦C,
50sec at 60◦C, 14min at 68◦C). Ampliﬁed products were
digested with Dpn I for 2 hours at 37◦Ct or e m o v e
template plasmid. XL1-Gold super competent E. coli cells
were transformed with the mutant plasmid mixture.
2.3. Screening for Increased Activity at Low Temperature.
pET-Ph1prol plasmids from the mutant P. horikoshii library
were transformed into the selective strain JD1(λDE3) and
were plated on M9 selective agar plates. Colonies that grew
after being incubated for 3–7d at 20◦C were isolated on
LB plates and then grown in 10mL LB medium at 37◦C
with shaking (200rpm) until an optical density of 0.6–0.8
was reached. IPTG was then added to the cell culture to
a ﬁnal concentration of 1mM. The induced culture was
shaken at 37◦C for 3h before harvesting the cells. These
cell pellets were lysed using 300μLo fB - p e rb u ﬀer (Thermo
Scientiﬁc, Rockford, Ill), and the resulting cell extracts were
used for enzyme activity assays conducted at 30◦Ca n da t
100◦C. Heat-treated soluble protein samples were heated
at 80◦C for 20min. Four mutant colonies that exhibited
at least 2-3-fold higher activities compared to the cells
expressing the wild type P. horikoshii prolidase were selected
for characterization, and their plasmids were isolated. The
prolidase genes present in those isolated plasmids were
sequencedusingtheT7promoterandT7terminatorprimers
(MWG Biotech, Huntsville, AL).
2.4. Large-Scale Expression of Recombinant P. horikoshii Prol-
idase Mutants. Production of P. horikoshii prolidase variants
(A195T/G306S-,Y301C/K342N-,E127G/E252D-,andE36V-
Ph1prol) was carried out in transformed E. coli BL21 (λDE3)
cells with the appropriate pET-Ph1prol plasmid and pRIL
vector. The transformants were grown in 1L cultures of
autoinduction media [21] incubated at 37◦C with shaking
(200 RPM) overnight.
2.5. Puriﬁcation of Recombinant P. horikoshii Prolidase
Mutants. Cell pellets from the four Ph1prol variants
(A195T/G306S-,Y301C/K342N-,E127G/E252D-,andE36V-
Ph1prol) were suspended in 50mM Tris-HCl, pH 8.0 (3mL
Tris per 1 gram of cell paste), with 1mM benzamidine and
1mM DTT. For each variant, diluted cell slurry was passed
through a French pressure cell (20,000lb/in2) three times.
Cell lysates were centrifuged at 38,720xg for 30min at 4◦C,
and then the supernatants were heated to 80◦Cf o r3 0m i n
anaerobically to denature any proteins not stable at that
temperature. Heat-treated supernatants were centrifuged at
38,720xg to remove the denatured proteins. Supernatants
were sampled both before and after heat treatment for
activity analysis. (NH4)2SO4 was added gradually to the
supernatants to make a ﬁnal concentration of 1.5 M prior
to loading onto a 5mL Phenyl-Sepharose hydrophobicArchaea 3
interaction chromatography column (Hi-Trap Phenyl HP
Column, GE Healthcare Life Sciences, Piscataway, NJ).
Fractions containing the prolidase mutants were pooled and
dialyzed overnight into 4L of 50mM Tris HCl, pH 8.0 at
4◦C, and were further puriﬁed on a 5mL Q Sepharose anion
exchange chromatography column (Hi-Trap Q FF Column,
GE Healthcare Life Sciences, Piscataway, NJ). Buﬀers for
bothpuriﬁcationstepshavebeendescribedin[16].Fractions
from both puriﬁcation steps were further visualized using
SDS-PAGE(12.5%SDS-polyacrylamidegels)andweretested
for enzyme activity. Fractions were then pooled based on
gel images, and enzyme stocks were stored at −80◦C. The
molecularweightsofPh1prolandmutantsareapproximately
40.04kDa. The purity of each Ph1prol mutant was estimated
to be greater than 95% using both visual inspection of SDS-
polyacrylamide gels and electrophoretic microchip analysis.
2.6. Prolidase Enzyme Activity Assay. T h ee n z y m ea c t i v i t y
assay protocol is based on a method previously described
by [17, 20]. The reaction mixture (500μL) contained 50mM
MOPS buﬀer (3-[N-morpholino] propanesulfonic acid) pH
7.0, 200mM NaCl, water, 5% (vol/vol) glycerol, 100μg/mL
BSA (bovine serum albumin) protein, 0.2mM CoCl2,a n d
the enzyme. The reaction mixture was heated at 100◦Cf o r
5min allowing time for the metal and enzyme to interact.
The reaction was initiated by the addition of substrate (Xaa-
Pro, 4mM ﬁnal concentration) and allowed to proceed for
10min at 100◦C. The reaction was stopped with 500μL
glacial acetic acid and 500μL ninhydrin reagent (3% (wt.
vol)) and heated again for 10min at 100◦C. The reaction
was then cooled to 23◦C. Prolidase samples were assayed
in triplicate and speciﬁc activity was calculated using the
absorbance value at 515nm and an extinction coeﬃcient of
4,570M−1cm−1 for the ninhydrin-proline complex.
For assays evaluating the temperature proﬁle, WT-
Ph1prol and the four prolidase mutants were assayed in
triplicate for activity with 4mM Met-Pro at 10◦C, 20◦C,
35◦C, 50◦C, 70◦C, and 100◦C. Experiments were performed
in duplicate.
2.7. Substrate Speciﬁcity and Kinetics Experiments. In order
to study substrate speciﬁcity, the following Xaa-Pro dipep-
t i d e sw e r eu s e da ss u b s t r a t e s( 4 m Mﬁ n a lc o n c e n t r a t i o n )
in the enzyme activity assays for WT-Ph1prol and the four
prolidase mutants: Val-Pro, Met-Pro, Phe-Pro, Leu-Pro, Ala-
Pro, and Gly-Pro. Prolidase samples were assayed with two
additional substrates, Pro-Ala and Val-Leu-Pro, to further
illustrate prolidase preference of Xaa-Pro dipeptides [20].
Kinetic parameters of the Ph1prol mutants were determined
at 70◦C using a range of Leu-Pro concentrations (0.25–
12mM).
2.8. Thermostability and Pot-Life Experiments. Thermosta-
bility experiments were performed in duplicate on WT-
Ph1prol and the four mutants. Each enzyme was diluted to a
concentration of 0.04mg/mL in 50mM MOPS, pH 7.0, and
200mM NaCl and incubated in an anaerobic sealed vial at
90◦C. An initial sample was taken to represent Time = 0h,
andadditionalsamplesweretakenatTime =24,48,and72h.
Samples were diluted to 0.4μg/mL in 50mM MOPS, pH
7.0, and 200mM NaCl and were then assayed in triplicate in
accordancewiththeenzymeactivityassayprotocoldescribed
in Section 2.6. In all cases, the substrate used in the activity
assay was 4mM Met-Pro.
Pot-life experiments were also performed in duplicate.
Each enzyme was diluted to a concentration of 0.04mg/mL
in 50mM MOPS, pH 7.0, and 200mM NaCl and incubated
anaerobically in a sealed vial at 70◦C. An initial sample was
taken to represent Time = 0 days, and additional samples
were taken at Time = 1, 7, 14, 16, and 21 days. Samples were
diluted to 0.4μg/mL in 50mM MOPS, pH 7.0, and 200mM
NaClandwerethenassayedintriplicatetodeterminespeciﬁc
activity.
2.9. DSC Experiment. Diﬀerential scanning calorimetry was
performed using a MicroCal VP-DSC scanning calorimeter.
The calorimetric samples contained ∼1mg/mL protein in
50mM MOPS, 200mM NaCl, 0.2mM CoCl2,p H7 . 0 .P r o -
tein samples were dialyzed 15h against this buﬀer before the
experiment. Samples were degassed before loading into the
chambercell.Thecalorimetricexperimentwasperformedby
heating the samples at a scan rate of 100◦C/hr.
2.10. DFP (diisopropylﬂuorophosphate) Assay. The hydrolysis
of DFP by prolidases was measured by monitoring ﬂuo-
ride release with a ﬂuoride-speciﬁc electrode as previously
described [22]. Assays were performed at 35◦Ca n d5 0 ◦C,
with continuous stirring in 2.5mL of buﬀer (50mM MOPS,
200mM NaCl, pH 7.0), 0.2mM CoCl2 and 3mM DFP.
T h ee n z y m ea n dm e t a lw e r ei n c u b a t e da tt h er e a c t i o n
temperature 5min prior to the start of the reaction. The
background of DFP hydrolysis was measured by running
a reaction without enzyme present at 35◦Ca n d5 0 ◦C.
The background hydrolysis of DFP was subtracted from
enzymatic hydrolysis to determine speciﬁc activity of the
enzyme.
2.11. p-Nitrophenyl Soman Assay (O-Pinacolyl p-Nitrophenyl
Methylphosphonate Activity). Prolidase hydrolysis of p-
nitrophenyl soman was monitored by accumulation of p-
nitrophenolate [10, 22]. The p-Nitrophenyl Soman was
synthesized at Edgewood Chemical Biological Center in
Aberdeen Proving Ground, Md. and contained a racemic
mixture of all four stereoisomers. The purity of the soman
analog was greater than 90% based on gas chromatography
analysis [12]. Two mL reaction assays contained buﬀer
(50mM MOPS, 200mM NaCl, pH 7.0), 0.2mM CoCl2,a n d
0.3mM p-nitrophenyl soman. The reactions were conducted
at three diﬀerent temperatures (35◦C, 50◦Ca n d7 0 ◦C).
The enzyme and metal were incubated at the speciﬁed
reaction temperature 5min prior to the start of the reaction.
Absorbanceoftheproductp-nitrophenolatewasmeasuredat
405nm over a 5min range. To calculate activity, the extinc-
tion coeﬃcient for p-nitrophenolate of 10,101 M−1 cm−1
was used.4 Archaea
3. Results andDiscussion
3.1. P. furiosus and P. horikoshii Prolidase-Speciﬁc Activities
with OP Nerve Agents: DFP and Soman Analog. Previous
studies characterizing P. horikoshii prolidase homolog 1
(Ph1prol, PH0974) demonstrated that it has higher catalytic
activity over a broader pH range, higher aﬃnity for metal,
and is more thermostable than either P. furiosus prolidase
(Pfprol, PF1343) or P. horikoshii prolidase (Phprol, PH1149)
when assayed with the dipeptide substrate Met-Pro [20].
BasedonthesefavorableattributesforPh1prolwhenreacting
with its natural substrates, Xaa-Pro dipeptides, there was
interest in determining the relative activity of recombi-
nant Ph1prol compared to Pfprol and Phprol against G-
type nerve agent simulants DFP and soman analog, p-
nitrophenylsoman. As indicated in Figure 1, DFP exhibited
the greatest hydrolysis with Ph1prol. Ph1prol had a relative
activity that was 843% higher than Pfprol and 817% higher
than Phprol at 35◦C and 1870% higher than both Pfprol
and Phprol at 50◦C( Figure 1). In contrast, the trends
with the soman analog were very diﬀerent as shown in
Figure 2. The relative activity of Ph1prol was only 70%, 63%,
and 68% of the Pfprol activity at 35◦C, 50◦C, and 70◦C,
respectively (Figure 2). These results indicate that Ph1prol
has a preference for DFP and does not exhibit high activity
with the soman analog. Diﬀerences in the protein structures
likely play a role in the substrate preference since Pfprol and
Ph1prol share only 55% amino acid residue similarity [16].
By altering the Ph1prol structure further using a random
mutagenesisapproach,itwouldbepossibletoisolatePh1prol
variants that show even greater hydrolysis of DFP and/or
improved activity against the soman analog.
3.2. Screening and Isolation of the Ph1prol Mutant Population
Using Proline Auxotrophic Strain JD1 (λDE3). Since Ph1prol
showed the most favorable properties including higher
activity with DFP, it was selected for further mutagenesis
usinganerror-pronePCRstrategy,whichemploysamutated
polymerase. Transformed E. coli JD1 (λDE3) cells were
used to select for Ph1prol variants on minimal media
plates that were supplemented with 20μM Leu-Pro and
grown at 20◦C. Colonies that were visible in 3–7 days
were plated on minimal and rich (LB) media. Ph1prol
variants were screened using small-scale expression cultures
(10mL) induced with IPTG. Four Ph1prol variants out
of over 200 screened were selected for sequencing after
showing two-fold higher activity with Leu-Pro at 30◦Ca n d
somewhat reduced activity at 100◦C as compared to wild
type. The increased activity at the lower temperature of
30◦C and variation at the higher temperature of 100◦Ci s
indicative of a mutation in a thermophilic protein, which
can compromise activity or stability at higher temperatures
butcouldcreatemoreﬂexibilityandincreasedcatalysisatthe
lower temperatures.
3.3. Sequencing of Ph1prol Mutants. Prior to sequencing, the
four Ph1prol mutants were numbered (10, 19, 35, and 72)
based solely on the order in which they had been isolated.
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Figure 1: Relative activity with WT-Pfprol and P. horikoshii
prolidases with OP nerve agent DFP. All prolidase assays contained
50mM MOPS, 200mM NaCl, pH 7.0, 0.2mM CoCl2, and 3mM
DFP. 100% relative activity corresponds to WT-Pfprol speciﬁc
activity for DFP of 0.42μmoles product formed/min/mg at 35◦C
and 0.73μmoles product formed/min/mg at 50◦C.
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Figure 2: Relative activity with WT-Pfprol and P. horikoshii
prolidase with OP nerve agent analog, p-nitrophenyl soman. All
prolidase assays contained 50mM MOPS 200mM NaCl pH 7.0,
0.2mM CoCl2, and 3mM p-nitrophenyl soman. One hundred
percent relative activity corresponds to WT-Pfprol-speciﬁc activity
for p-nitrophenyl soman of 0.26μmol product formed/min/mg at
35◦C, 0.33μmol product formed/min/mg at 50◦C, and 0.56μmol
product formed/min/mg at 70◦C.
Sequencing of the variants revealed the locations of the
amino acid substitutions for each mutant (Figure 3). Mutant
no.10 has two mutations: one at position 195 in which
there is a change from alanine to threonine (A195T) and
the second at amino acid residue 306 in which glycine is
changed to serine (G306S). Both of these mutations resideArchaea 5
in the C-terminal region of Ph1prol. Mutant no.19 has
two mutations: one at position 301 in which there is a
change from tyrosine to cysteine (Y301C) and the second at
amino acid residue 342 which has a substitution of lysine
with an asparagine (K342N). Both of these mutations are
in the C-terminal region of the enzyme. Mutant no.35
contains two mutations: one at position 127 in the α-helical
linker region in which there is a change from glutamate to
glycine (E127G) and the second in the C-terminal region at
position 252 with a substitution of glutamate for aspartate
(E252D). Mutant no.72 is the only mutation in the N-
terminal region at position 36 with a change from glutamate
to valine (E36V) in Ph1prol. The mutations are remote
from the active site pocket, which is shown in Figure 3 as
being located between two 310 helixes (red helices, residues
191–195, and 281–284). Therefore, the mutations are not
likely directly changing the active site chemistry. Rather the
mutations such as E36V, E127G, and Y301C may be aﬀecting
prolidasedimerizationasthoseresiduesarelocatedalongthe
dimerization interface. Furthermore, the mutations may be
aﬀecting the conformational dynamics of the enzymes since
some of the mutations are located in the loop and linker
regions. The change in conformation dynamics is giving the
variants better activity over a broader range of temperatures
as indicated in Section 3.4.
3.4. Eﬀects of Mutagenesis on the Temperature Proﬁle of P.
horikoshiiProlidaseVariants. BoththewildtypePh1proland
the four variants were most active at 100◦C( Figure 4). WT-
Ph1prol and E36V-Ph1prol had very high speciﬁc activities
(3,955U/mg and 4094U/mg, resp.) with 4mM Met-Pro,
both of which are twice as high as that of Pfprol at 100◦C
(2,154U/mg) [21]. A195T/G306S- and E127G/E252D-
Ph1prol were slightly less active (2,307U/mg and
2,831U/mg, resp.) than WT Ph1prol, and Y301C/K342N-
Ph1prol showed the lowest level of activity in comparison to
the other mutants at 1,842U/mg. Activity was reduced by
more than half at 70◦C for all of the variants; however, WT-
Ph1prol, A195T/G306S-, and E36V-Ph1prol all had speciﬁc
activities close to 1,000U/mg (973U/mg, 1000U/mg, and
913U/mg, resp.), whereas the speciﬁc activity of Pfprol at
70◦C was 806U/mg [21]. At 50◦C, Y301C/K342N-Ph1prol
had a higher speciﬁc activity than any of the other variants
and the wild type (450U/mg) and was roughly three times
more active than Pfprol at 50◦C[ 21].
At the lower temperatures, 35◦C, 20◦Ca n d1 0 ◦C,
Y301C/K342N-Ph1prol out-performs the other Ph1prol var-
iants, the WT-Ph1prol, the WT-Pfprol and R19G/G39E/
K71E/S229T-Pfprol (the highest performing Pfprol mutant
at lower temperatures) [21]. At 35◦C, Y301C/K342N-
Ph1prol (298U/mg) has relative activity that is 121% that
of WT-Ph1prol, 489% that of WT-Pfprol, and 244% that
of R19G/G39E/K71E/S229T-Pfprol (246U/mg, 61U/mg,
and 122U/mg, resp.). At 20◦C, Y301C/K342N-Ph1prol
(241U/mg) has a relative activity 184% that of WT-
Ph1prol, 964% higher than WT-Pfprol, and 482% higher
than R19G/G39E/K71E/S229T-Pfprol (speciﬁc activities of
131U/mg for WT-Ph1prol, 25U/mg for WT-Pfprol and
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Figure 3: Mapping of the mutations in the monomeric structure
of P. horikoshii prolidase (Ph1prol or PH0974). Mutations made
in the Ph1prol are indicated by colored arrows where red indi-
cates mutations present in Mutant no.10 (A195T/G306S-Ph1prol),
orangeindicatesmutationsinMutantno.19(Y301C/K342N),green
indicates mutations in Mutant no.35 (E127G/E252D), and blue
indicates mutations in Mutant no.72 (E36V). The domain structure
of Ph1prol is presented as a ribbon drawing where the N-terminal
(residues 1–120) and C-terminal (131–356) domains are labeled
and are connected by a α-helical linker at residues 121–130. The
putative active site pocket is located between two 310 helixes (two
red helices, residues 191–195 and 281–284) (modiﬁed from [18]).
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Figure 4:TemperatureproﬁleofWT-Ph1prolandthefourvariants.
Relative activities are shown as a percentage of the WT-Ph1prol.
Prolidase assays were performed in triplicate at 10◦C, 20◦C,
35◦C, 50◦C, 70◦C, and 100◦C and contained 0.2mM CoCl2 and
4mMMet-Pro.WT -Ph1prol-speciﬁc activity was 66U/mg at 10◦C,
131U/mg at 20◦C, 246U/mg at 35◦C, 340U/mg at 50◦C, 973U/mg
at 70◦C, and 3,955U/mg at 100◦C.6 Archaea
50U/mg for R19G/G39E/K71E/S229T-Pfprol) [21]. The
greatest improvement in performance for the Ph1prol mu-
tants is seen when assayed at 10◦C. Y301C/K342N-Ph1prol
(109U/mg) has a relative activity that is 166% higher than
that of WT-Ph1prol, 1,982% higher than that of WT-Pfprol,
and 396% higher than R19G/G39E/K71E/S229T-Pfprol
(speciﬁc activities of 66U/mg for WT-Ph1prol, 5.5U/mg for
WT-Pfprol, and 27.5U/mg for R19G/G39E/K71E/S229T-
Pfprol) [21].
3.5. Eﬀects of Mutagenesis on Substrate Speciﬁcity and Kinetics
of P. horikoshii Prolidase Variants. Substrate speciﬁcity of
WT-Ph1prolisshowninTable 1 alongwiththespeciﬁcactiv-
ities of A195T/G306S-, Y301C/K342N-, E127G/E252D-, and
E36V-Ph1prol, which are reported as a percentage relative to
the activity of the wild type. WT-Ph1prol was most active
with the dipeptide Val-Pro (4,602U/mg), while mutants
A195T/G306S-, Y301C/K342N-, E127G/E252D-, and E36V-
Ph1prol had much lower activity at 33%, 36%, 46%,
and 56% of the WT Ph1prol, respectively. A195T/G306S-
Ph1prol showed the highest activity with Met-Pro at 143%
that of the wild type (2,809U/mg), while Y301C/K342N-,
E127G/E252D-, and E36V-Ph1prol preferred Ala-Pro with
speciﬁc activities of 183%, 324%, and 556% that of WT-
Ph1prol (1,452U/mg). WT-Ph1prol seems to prefer the most
hydrophobic amino acids, while the four variants have the
highest activity with a less hydrophobic amino acid in the N-
terminal position of the dipeptide substrate. While alanine
is considered to be a hydrophobic amino acid, it is less
hydrophobic than valine, methionine, phenylalanine, and
leucine and is most similar in structure to glycine. WT-
Ph1prol has much lower activity with Gly-Pro than with
Ala-Pro (369 compared to 1,452U/mg). A195T/G306S-,
Y301C/K342N-, and E127G/E252D-Ph1prol have less or
similar activity with Gly-Pro as compared to WT-Ph1prol
(369U/mg) while E36V-Ph1prol has 444% higher activ-
ity.
Speciﬁc activities were consistently low with both Pro-
Ala and Val-Leu-Pro (2U/mg, WT-Ph1prol) for the wild
type Ph1prol and the four mutants. Due to the nature of
the prolidase enzyme and its unique ability to cleave the
bond between Xaa-Pro dipeptides, it was expected that the
enzyme would not show any notable activity with a Pro-
Xaa dipeptide or a tripeptide. While two of the four variants
(mutants A195T/G306S- and E36V-Ph1prol) show increased
activitywith Pro-Alawhencomparedto wildtype, it must be
noted that speciﬁc activity with Pro-Ala for WT-Ph1prol was
extremely low, at only 14U/mg. Y301C/K342N-Ph1prol had
88% WT activity with Val-Leu-Pro; however, WT-Ph1prol-
speciﬁc activity was only 2U/mg.
The catalytic activities of WT-Ph1prol and its mutants
were tested at 70◦C with Leu-Pro (Table 2). All Ph1prol
mutants had higher kcat values than the WT-Ph1prol sug-
gesting that the amino acid changes in the mutant enzymes
did have an eﬀect on structure and ultimately the catalytic
activityoftheprolidasewiththesubstrateLeu-Pro.Although
the kcat values were higher, the overall enzyme turnover rates
were not for some of the mutants compared to WT-Ph1prol.
Table 1: Substrate speciﬁcity of recombinant wild type and variant
P. horikoshii prolidases with diﬀerent proline dipeptides and a
single-proline tripeptide.
Substrate Relative Activity (%) of WT-Ph1prol-speciﬁc activity
WT-
Ph1prol
A195T/
G306S-
Ph1prol
Y301C/
K342N-
Ph1prol
E127G/
E252D-
Ph1prol
E36V-
Ph1prol
Val-Pro 100 33 36 46 56
(4,602)
Met-Pro 100 143 33 117 77
(2,809)
Phe-Pro 100 116 53 53 68
(2,199)
Leu-Pro 100 116 36 90 65
(2,132)
Ala-Pro 100 219 183 324 556
(1,452)
Gly-Pro 100 94 52 107 444
(369)
Pro-Ala 100 137 33 75 332
(14)
Val-Leu-Pro 100 0 88 0 0
(2)
Prolidase assays were performed at 100◦C and contained 0.2mM CoCl2 and
4mMofeachsubstrate.Onehundredpercentspeciﬁcactivityisreportedfor
WT-Ph1prol and correlates to U/mg in parentheses below the 100% relative
activity.
Table 2: Kinetic parameters of wild type Pyrococcus horikoshii
prolidase, Ph1prol, and prolidase variants with Leu-Pro at 70◦C.
Prolidase Km
(mM)
Vmax
(μmol/min/mg)
kcat
(s−1)
kcat/Km
(mM−1s−1)
WT-Ph1prol 0.92 ± 0.16 809 ± 55 1079 1172
A195T/G306S 0.81 ± 0.26 1245 ± 149 1660 2049
Y301C/K342N 2.92 ± 0.40 2146 ± 177 2861 980
E127G/E252D 0.98 ± 0.24 1119 ± 101 1492 1522
E36V 1.6 ± 0.37 1597 ± 174 2129 1331
Enzyme assays were done using a range of Leu-Pro concentrations (0.25–
12mM). Enzyme kinetics were calculated using nonlinear regression (curve
ﬁt) and analyzed using the Michaelis-Menten equation utilizing software
from Prism 5 (GraphPad La Jolla, CA). All Ph1prol assays contained 0.2mM
CoCl2.
All the Ph1prol mutants showed an increased turnover rate,
kcat/Km, with Leu-Pro except for Y301C/K342N-Ph1prol.
This could be due to the increase in the Km of this mutant,
which is almost three times higher than WT-Ph1prol.
3.6. Eﬀects of Amino Acid Substitutions on the Thermostability
and Pot-Life Activity of P. horikoshii Prolidase Mutants. To
determine whether the amino acid substitutions in the
four Ph1prol variants had any eﬀect on thermostability, the
mutants were incubated in sealed vials at 90◦C, anaerobi-
cally, for 72h. Samples were taken every 24h to measureArchaea 7
catalytic activity with Met-Pro (4mM) as the substrate. In
Theriot et al. 2010, it was shown that WT-Pfprol was more
thermostable than its mutants and had lost 50% activity
with Met-Pro by 21 hours at 90◦C[ 20]. After 40h at 90◦C,
WT-Ph1prol had lost 50% activity. Mutants Y301C/K342N-
Ph1prol and E127G/E252D-Ph1prol both demonstrated
increased thermostability at 90◦C compared to wild type and
had lost 50% activity after 58 hours of incubation. Mutants
A195T/G306S-Ph1prol and E36V-Ph1prol displayed a 50%
loss of activity after 32 and 35 hours at 90◦C, respectively.
Both WT-Ph1prol and the four Ph1prol mutants were stable
at90◦CforasigniﬁcantlylongertimeperiodthanPfproland
its mutants [20].
Pot-life activity was monitored over the course of 21
days with samples taken every seven days until day 14
and then again on days 16 and 21 while the samples
were incubated anaerobically at 70◦C( Figure 5). Pot-life
experiments with WT-Pfprol and its mutants as reported
in Theriot et al., 2010 were conducted over a 48h period
at 70◦C[ 20]. In preliminary pot-life experiments with
WT-Ph1prol and its mutants, the speciﬁc activities with
Met-Pro were still remarkably high after 48h (no obvi-
ous decrease in speciﬁc activity was detected; data not
shown), so the experiments were continued until the
enzymes were considered to be no longer active (21 days).
Initial speciﬁc activities for WT-Ph1prol, A195T/G306S-,
Y301C/K342N-, E127G/E252D-, and E36V-Ph1prol were
3,150U/mg, 3,400U/mg, 1,250U/mg, 2,200U/mg, and
3,600U/mg, respectively, with 4mM Met-Pro as the sub-
strate. WT-Ph1prol had lost 50% activity by day 12 of incu-
bation at 70◦C. Mutants Y301C/K342N-, E127G/E252D-,
and E36V-Ph1prol had 50% activity remaining by days 12,
13, and 14, respectively. A195T/G306S-Ph1prol was at 50%
activity after 10 days at 70◦C. By 21 days at 70◦C, all ﬁve
prolidases were at or below 25% of the initial activity.
As reported in Theriot et al., 2010, the speciﬁc
activities of WT-Pfprol and its three mutants (G39E-,
R19G/K71E/S229T-, and R19G/G39E/K71E/S229T-Pfprol)
were 1,083U/mg, 599U/mg, 722U/mg, and 4,496U/mg,
respectively, with 4mM Met-Pro after 48h of incubation at
70◦C[ 20]. In contrast, after 7 days (or 168h) at 70◦C, WT-
Ph1prol, A195T/G306S-, Y301C/K342N-, E127G/E252D-,
and E36V-Ph1prol had speciﬁc activities of 2,950U/mg,
3,050U/mg, 1,230U/mg, 2,650U/mg, and 2,400U/mg,
respectively, with 4mM Met-Pro. After 48h at 70◦C, WT-
Pfprol had a higher speciﬁc activity than any of its mutants
(1,083U/mg). After 7 days at 70◦C, Y301C/K342N-Ph1prol
showed the lowest speciﬁc activity of the Ph1 prolidases;
however, it still had activity 114% that of WT-Pfprol at 48h
[20].
3.7. DSC Results. The thermal stability of wild type Ph1prol
and variants was determined by diﬀerential scanning
calorimetry (DSC) experiments. Table 3 shows the denatura-
tion temperature of the wild type and variant enzymes. The
mutations that improved catalytic activity of the Ph1prol at
lower temperatures did not adversely aﬀect the temperature
stability of the enzymes.
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Figure 5: Pot-life activity of WT-Ph1prol and prolidase mutants
incubated anaerobically at 70◦C. Pot-life experiments were per-
formed in duplicate and samples were taken at 0, 1, 7, 14, 16,
and 21 days to assess reactivity. Prolidase assays were performed in
triplicate at 100◦C and contained 0.2mM CoCl2 and 4mM Met-
Pro. Error bars in Figure 5 represent standard deviation of speciﬁc
activity across duplicate runs.
Table 3: Transition temperature of wild type Pyrococcus horikoshii
prolidase, Ph1prol, and prolidase variants at pH 7.0.
Prolidase Tm(◦C)
WT-Ph1prol 114.3 ± 1.1
A195T/G306S1 114.4 ± 0.1
Y301C/K342N 113.8 ± 0.6
E127G/E252D 112.2 ± 0.5
E36V 114.9 ± 1.3
Tm is the transition temperatures obtained from the analysis of DSC by
usingthetwo-statemodel.TheTm valuesarethemeanofthreeindependent
measurements. 1The Tm value is from two independent measurements.
3.8. Eﬀects of Amino Acid Substitutions on Substrate Speciﬁcity
with OP Nerve Agents DFP and Soman Analog, p-Nitrophenyl
Soman. Substrate speciﬁcity of WT-Ph1prol with DFP is
shown in Figure 6 along with the speciﬁc activities of
A195T/G306S-, Y301C/K342N-, E127G/E252D-, and E36V-
Ph1prol, which are reported as a percentage relative to the
activity of the wild type. WT-Ph1prol was most active with
DFP at 35◦Ca n d5 0 ◦C with a speciﬁc activity of 4U/mg
and 10U/mg, respectively. The mutants A195T/G306S,
Y301C/K342N-, E127G/E252D-, and E36V-Ph1prol had
signiﬁcantly lower activity with DFP; even at 50◦C the
activity was only 59%, 25%, and 55% of WT-Ph1prol
activity. However, it should be noted that the Ph1prol
mutants have 808%, 183%, and 402% (A195T/G306S,
Y301C/K342N-, E127G/E252D-, and E36V-Ph1prol, resp.)
of the DFP activity compared to WT P. furiosus prolidase and
also compared favorably to the highest DFP activity reported8 Archaea
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Figure 6: Relative activity with WT-Ph1prol and prolidase mutants
with OP nerve agent DFP. All prolidase assays contained 50mM
MOPS 200mM NaCl pH 7.0, 0.2mM CoCl2, and 3mM DFP.
One hundred percent relative activity corresponds to WT-Ph1prol
speciﬁc activity for DFP of 4μmol product formed per minute per
milligram at 35◦Ca n d1 0μmol of product formed per minute per
milligram at 50◦C.
for the R19/G39E/K71E/S229T Pfprol mutant, which was
shown to have 398% higher activity than WT Pfprol
[21].
Figure 7 reveals a diﬀerent trend, where the mutations
in WT-Ph1prol increased the speciﬁc activity with the
soman analog, p-nitrophenyl soman. WT-Ph1prol showed
the highest activity with the soman analog at 70◦C, with a
speciﬁc activity of 0.56U/mg. The mutant A195T/G306S-
Ph1prol had a similar speciﬁc activity to WT-Ph1prol when
incubatedat35◦C,50◦C,and70◦C.MutantsY301C/K342N-,
E127G/E252D-, and E36V-Ph1prol showed increased activ-
ity with the soman analog over WT-Ph1prol at each
assay temperature. The most signiﬁcant speciﬁc activities
with the soman analog were seen with Y301C/K342N-,
E127G/E252D-, and E36V-Ph1prol at 70◦C, which cor-
related to 125%, 186%, and 157% increase over WT-
Ph1prol. Furthermore, the activities for the Ph1prol mutants
against p-nitrophenyl soman (0.7, 1.0, and 0.9U/mg for
Y301C/K342N-, E127G/E252D-, and E36V-Ph1prol, resp.)
compare favorably to the improved soman analog activi-
ties reported for the P. furiosus prolidase mutants (0.86,
1.02, and 1.7U/mgfor G39E-, R19G/K71E/S229T-, and
R19G/G39E/K71E/S229T-Pfprol, resp.) [20]. When looking
at the substrate speciﬁcity of the WT-Ph1prol and variants
with proline dipeptides, it was noticed that there was a shift
in preference from more hydrophobic to less hydrophobic
amino acids among the mutants. This is also seen with the
OP nerve agents, where there is a shift in substrate speciﬁcity
from DFP to the soman analog. The WT-Ph1prol prefers
DFP as a substrate over the soman analog, while the Ph1prol
variants show decreased activity with DFP and increased
activity with the soman analog.
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Figure 7: Relative activity with WT-Ph1prol and prolidase mutants
with OP nerve agent analog, p-nitrophenyl soman. All prolidase
assays contained 50mM MOPS 200mM NaCl pH 7.0, 0.2mM
CoCl2, and 3mM p-nitrophenyl soman. One hundred percent
relative activity corresponds to WT-Ph1prol speciﬁc activity for
p-nitrophenyl soman of 0.26μmol product formed per minute
per milligram at 35◦C, 0.33μmol product formed per minute per
milligram at 50◦C, and 0.56μmol product formed per minute per
milligram at 70◦C.
4. Conclusion
Current biodecontamination formulations for degradation
of OP nerve agents that incorporate Alteromonas prolidases
(OPAA) and PTE have limitations when used in the ﬁeld
[12]. Long-term stability of the enzyme is not attainable
in a formulation mixture that includes other solvents and
denaturing solutions, and the need to add excess metal to
reach maximum activity poses further complications for an
enzyme-based detoxiﬁcation system. A highly active enzyme
that is stable over the long term and requires very little metal
addition would be best suited for this application. The wild
type and mutant prolidases characterized from P. horikoshii
show promising enzymatic properties that make them
potential candidates for future optimization studies for OP
nerve agent degradation. Compared to Pfprol, Ph1prol and
thefourPh1prolmutantsshowhigheractivity,higheraﬃnity
for the substrate, and signiﬁcantly lower metal requirement
for catalysis. Two of the variants, Y301C/K342N- and
E127G/E252D-Ph1prol are thermostable for nearly three
times as long as Pfprol and double the time of Ph1prol.
A195T/G306S-Ph1prol has 808% of the DFP activity com-
pared to wild type P. furiosus prolidase and is superior to
any of the improved P. furiosus prolidase mutants [21].
Furthermore, Y301C/K342N-, E127G/E252D-, and E36V-
Ph1prol all have improved activities against p-nitrophenyl
soman relative to WT-Ph1prol and also compare favorably
to the best performing P. furiosus prolidase mutants [20].
The Ph1prol variants have the potential to signiﬁcantly
improve upon current biodecontamination strategies. Their
increased thermostability and pot life and activities againstArchaea 9
OPnerveagentanalogswarrantfurtherstudyintolarge-scale
production and puriﬁcation of these prolidases.
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